...
首页> 外文期刊>Science >Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels
【24h】

Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels

机译:剪切激活的纳米治疗药物靶向阻塞的血管

获取原文
获取原文并翻译 | 示例
           

摘要

Obstruction of critical blood vessels due to thrombosis or embolism is a leading cause of death worldwide. Here, we describe a biomimetic strategy that uses high shear stress caused by vascular narrowing as a targeting mechanism-in the same way platelets do-to deliver drugs to obstructed blood vessels. Microscale aggregates of nanopartides were fabricated to break up into nanoscale components when exposed to abnormally high fluid shear stress. When coated with tissue plasminogen activator and administered intravenously in mice, these shear-activated nanotherapeutics induce rapid clot dissolution in a mesenteric injury model, restore normal flow dynamics, and increase survival in an otherwise fatal mouse pulmonary embolism model. This biophysical strategy for drug targeting, which lowers required doses and minimizes side effects while maximizing drug efficacy, offers a potential new approach for treatment of life-threatening diseases that result from acute vascular occlusion.
机译:由血栓形成或栓塞引起的关键血管阻塞是全球范围内死亡的主要原因。在这里,我们描述了一种仿生策略,该策略使用由血管变窄引起的高剪切应力作为靶向机制,以与血小板相同的方式将药物递送至阻塞的血管。当暴露于异常高的流体剪切应力时,纳米级微粒的微型聚集体被制造成分解成纳米级组件。当用组织纤溶酶原激活物包被并在小鼠中静脉内施用时,这些剪切激活的纳米疗法可在肠系膜损伤模型中诱导血凝块快速溶解,恢复正常的血流动力学,并在其他致命的小鼠肺栓塞模型中提高生存率。这种用于药物靶向的生物物理策略可降低所需剂量并最大程度地降低副作用,同时最大程度地提高药物疗效,为治疗由急性血管闭塞引起的威胁生命的疾病提供了一种潜在的新方法。

著录项

  • 来源
    《Science》 |2012年第6095期|p.738-742|共5页
  • 作者单位

    Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA;

    Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA;

    Vascular Biology Program, Departments of Pathology and Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115,USA,Department of Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA;

    Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115, USA,Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA 02115, USA;

    Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115, USA,Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA 02115, USA;

    Vascular Biology Program, Departments of Pathology and Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115,USA;

    Vascular Biology Program, Departments of Pathology and Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115,USA;

    Vascular Biology Program, Departments of Pathology and Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115,USA;

    Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA,School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA;

    School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA;

    Mechanical and Industrial Engineering, Northeastern University, Boston, MA 02115, USA;

    Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, MA 02115, USA;

    Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115, USA,Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA 02115, USA;

    Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA,Vascular Biology Program, Departments of Pathology and Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115,USA,School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号